Meet OMO – A Smart Home Solution Founded in Ukraine That Seeks to Renovate the IoT Industry
LOS ANGELES–(BUSINESS WIRE)–OMO Systems, an IoT solutions company founded in Kyiv, Ukraine, develops and implements…
News
KonoSuba: Fantastic Days Celebrates Its First Anniversary With a 4 Star Legendary Festival Event
New Quests, Events, and Celebratory Reward Bonuses Await KonoFans! LOS ANGELES–(BUSINESS WIRE)–#KonoSuba—KonoSuba: Fantastic Days, Nexon’s…
ESG tech sector M&A momentum on the rise as regulators and investors demand robust reporting, reveals Hampleton Partners
93 M&A deals globally target ESG firms in the first half of 2022 London, UK…
Sorrento Announces Significant Positive Pivotal Trial Results as Assessed by an Independent Review Committee (IRC) With Matured Long-Term (Over Three Years) Follow-Up Data of Abivertinib for the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
Abivertinib is a novel third-generation epidermal growth factor receptor (EGFR) inhibitor that irreversibly targets mutant…
Acer Therapeutics to Participate in August and September 2022 Investor Conferences
NEWTON, Mass., Aug. 23, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical…
Marijuana Strategic Ventures, Inc. (OTC: MSVI) Now Mushrooms Inc., Announces Filing of Provisional Patent for Novel Mycelium Thread
Mycothread Manufacturing Patent Exclusively Licensed to Company ESTERO, Fla., Aug. 23, 2022 (GLOBE NEWSWIRE) —…
Recce Pharmaceuticals Announces Positive Safety Data from Seventh Cohort of Phase 1 Clinical Trial Evaluating Healthy Subjects Intravenously Dosed with RECCE® 327
Highlights: 10 subjects in cohort seven were intravenously dosed with RECCE® 327 at 6,000mg Independent…
Erasca and MD Anderson Announce Strategic Research and Development Collaboration in RAS/MAPK-Driven Cancers
Initial focus of five-year collaboration will be on potentially best-in-class ERK1/2 inhibitor ERAS-007 and SHP2…
Beyond Air® Affiliate Beyond Cancer™ Doses Initial Patient in First-in-Human Phase 1 Study of Ultra-High Concentration Nitric Oxide Therapy at Tel Aviv Sourasky Medical Center (Ichilov)
GARDEN CITY, N.Y. and HAMILTON, Bermuda, Aug. 23, 2022 (GLOBE NEWSWIRE) — Beyond Cancer, Ltd.,…
Biolog-id and Genesis Growth Tech Acquisition Corp. Announce Execution of Memorandum of Understanding for a Proposed Merger to Create Publicly Listed Digital Health Solutions Company Focused on Value Chain Optimization
Anticipated Cash Resources to be used to Advance Biolog-id Value Chain Optimization Platform for Blood…
Windtree Therapeutics Announces KL4 Surfactant and AEROSURF® Global License Agreement
Windtree may receive up to $78.9 million in development, regulatory and commercial milestones plus low double…
mRNA Leading Expert Kenneth Chien and Novalis LifeSciences’ Marijn Dekkers Investing EUR 39M Series B2 Financing in mRNA Technology Platform Company eTheRNA
Financing round led by Novalis LifeSciences LLC Both investors Dr. Marijn Dekkers and Moderna’s co-founder…
Seer Announces Publication of Seminal Study Demonstrating the Power of Engineered Nano-Bio Interactions to Enable Deep Access to the Proteome
Published results highlight how the combination of proteomic methods, nanoengineering and machine learning enables the…
Reflect Scientific Inc. Opens New Showroom for Cryometrix Refrigeration and Coldchain Management Products
OREM, Utah, Aug. 23, 2022 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a provider…
Arcutis Completes Enrollment in INTEGUMENT-2 Pivotal Phase 3 Trial of Roflumilast Cream in Atopic Dermatitis
A total of 683 adults and children, age 6 years and older, have been enrolled…
Acerus Announces Resignation of CFO Effective November 20, 2022
TORONTO, Aug. 23, 2022 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP;…
Sensei Biotherapeutics to Participate in Upcoming Investor Conferences
BOSTON, Aug. 23, 2022 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), an immuno-oncology company…
NightHawk Biosciences Announces Buildout of Advanced Biosafety Level 2 (BSL-2) Laboratory
Further Enhances Research Capabilities in Infectious Disease and Biodefense DURHAM, N.C., Aug. 23, 2022 (GLOBE…
Plus Therapeutics to Present Data from ReSPECT-GBM™ Clinical Trial at the European Society for Medical Oncology Congress 2022
AUSTIN, Texas, Aug. 23, 2022 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
Tilray Medical Receives Verification From the Natural Health Science Foundation in Australia and New Zealand
Natural Health Science Foundation Assessment Further Verifies Tilray Medical’s High-Quality Standard and its CBD100 Product…